Background: The aims of this study were to investigate the utility of neutrophil-to-lymphocyte ratio (NLR) as a simple and readily available predictor for clinical disease activity in infl ammatory bowel disease (IBD). Methods: Sixty-six patients (22 CD, 44 UC) and 41 healthy controls were enrolled in the study. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) levels and complete blood count (CBC) were measured. The neutrophil and lymphocyte counts were recorded and NLR was calculated. The patients with active or inactive UC and CD were classifi ed according to the severity of the disease. Result: The serum NLR values of active CD patients were signifi cantly higher than those of inactive ones and controls (p = 0.000, p = 0.000, respectively). NLR values of active UC patients were signifi cantly higher than those of inactive ones and controls (p = 0.000, p = 0.000, respectively. The optimum NLR cut-off point for active CD and UC was 3.2 and 3.1.
Introduction
Infl ammatory bowel disease (IBD) has been a global healthcare problem with a sustained increasing incidence (1). It includes two major forms, Crohn's disease (CD) and ulcerative colitis (UC), which are distinct chronic bowel-relapsing infl ammatory disorders. In a non-continuous type, CD can cause transmural infl ammation and affect any part of the gastrointestinal tract (most commonly, the terminal ileum or perianal region). Unlike UC, CD is commonly associated with complications such as abscesses, fi stulas and strictures. In contrast, UC is typifi ed by mucosal infl ammation and limited to the colon (2) . After the diagnosis, it is crucial to monitor the disease via clinical, endoscopic, and laboratory indices of infl ammatory activity in CD. Among the indices of clinical activity, the CDAI (Crohn's disease activity index) and Harey-Bradshow index (HDI) are the most widely used (3) (4) (5) (6) (7) (8) . CDAI is considered the gold standard for assessing the activity of the disease because this validated index has been widely used for more than 25 years in clinical protocols and in studies seeking drug approval (9) . It is important to determine disease activity of UC early as this will signifi cantly reduce the surgery rate, and therefore reduce mortality in patients with serious UC (10) . Noninvasive markers, such as Creactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cells (WBCs) are widely acknowledged as important for both initial diagnosis and precise monitoring of disease activity in UC (11) . Nevertheless, no optimal test has been developed so far. Therefore, the adjunctive use of additional serum markers may add a signifi cant advantage for predicting disease severity and achieving diagnostic precision. Blood neutrophil-to-lymphocyte (NLR) ratio is a simple marker of subclinical infl ammation that can be easily obtained from the differential WBC count. In recent years, neutrophilia and relative lymphocytopenia were shown to be independent predictors of mortality in patients with acute heart failure (12) (13) (14) . In addition, recent studies introduce NLR as a potential marker to determine infl ammation in both cardiac and non-cardiac disorders (15) (16) (17) (18) . The aims of this study were to investigate the utility of NLR as a simple and readily available predictor for clinical disease activity in IBD.
Materials and methods

Patients and methods
This retrospective study evaluated the diagnostic value of NLR for disease activity in 63 IBD (21 CD, 42 UC) patients managed at the Internal Medicine and Gastroenterology Departments of Afyon Kocatepe University Faculty of Medicine Hospital between September 2008 and August 2013. The control group consisted of 41 healthy subjects matched as to their age and gender (male/ female -14/27).
Although 137 IBD patients were retrospectively reviewed, only 63 patients met study criteria. Patients were excluded from the study if they had hypertension, any acute infl ammation, infection, acute or chronic renal failure, chronic liver or heart diseases, coronary artery disease, connective tissue diseases or were drug users with changing number of leukocytes.
The diagnosis of IBD was based on standard clinical, radiological, endoscopic and histological criteria. The data were extracted from the hospital database as follows -age, sex, localization of the disease, disease duration, drug intake and other medical history. Complete blood count (CBC), ESR, and CRP were also recorded for each IBD patient. All CBC analyses were performed in the hematology laboratory of our hospital. CBC analysis was performed with the same analyzer within two hours from collection of blood samples with the use of a Beckman Coulter (High Wycombe, UK) Gen-S automated analyzer. NLR was calculated from the differential count by dividing the absolute neutrophil count by the absolute lymphocyte count. Conditions possibly affecting NLR, such as prior treatment with corticosteroids, hematological or neoplastic disorders, diabetes mellitus, acute and chronic renal failure, rheumatic diseases and clinical evidence of active infection were defi ned as exclusion criteria for entry into the study. The study was conducted in accordance with the guidelines of the Helsinki declaration.
Disease activity
The disease activity in UC patients was assessed by Truelove and Witts criteria. These criteria have been validated for over 50 years and allow a simple and rapid stratifi cation of patients with UC. Using this classifi cation, UC patients were classifi ed as mild, moderate or severe based on the number of bloody stools per day, heart rate, hemoglobin, ESR, and body temperature. Patients categorized as having moderate or severe disease were accepted as having active UC, whereas the patients in the mild group were considered to be in the remission period. The activity of Crohn's disease was evaluated by the physician with Harvey-Bradshaw index (1980) which is strongly correlated with Crohn's disease activity index (CDAI) and is easier to use. It evaluates fi ve clinical parameters including well-being, abdominal pain, number of liquid stools each day, abdominal mass, and complications. A score inferior to 4 indicates an inactive disease while that above 4 indicates that the disease is active. The patients included in the present study within the activation period were reassessed two months after clinical remission. NLR values of IBD patients in whom clinical remission was achieved were noted.
Statistical analysis
The Statistical Package for Social Sciences (SPSS) 18.0 for Windows was used to analyze the data. Continuous variables were tested for normality by the Kolmogorov-Smirnov test. Values were presented as mean ± standard deviation or in case of non-normally distributed data, as median and range. Comparisons of percentages between different groups of patients were carried out using the chi 2 test. All normally distributed data were analyzed using unpaired or paired student t test. Data found to be non-normally distributed were analyzed using Mann-Whitney U test for independent subgroups, and Wilcoxon test for dependent subgroups.
Receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of NLR, WBC, CRP and ESR with maximum sensitivity and specifi city for differentiation of activation of IBD from remission. Spearman's correlation analysis was done between NLR and other infl ammation markers. A p value of less than 0.05 was deemed statistically signifi cant.
Results
The mean age of CD and control groups was 34.40 ± 12.02 and 39.33 ± 7.77 years, respectively (p = 0.847). The mean age of the UC and control groups was 39.40 ± 11.15 and 39.33 ± 7.77 years, respectively (p = 0.173). There were no statistically signifi cant differences in age between study participants. The demographic and laboratory features of CD, UC and control group are 
Tab. 2 Demographic and laboratory features UC (active, inactive) patients and controls.
summarized in Tables 1 and 2 . The mean NLR values of active CD patients and controls were 5.25 ± 1.85 and 1.68 ± 0.59, respectively (P = 0.000). The mean NLR values of inactive CD patients and controls were 1.78 ± 0.32 and 1.68 ± 0.59p-inactive period) CD patients and controls are summarized in Table 1 . The mean NLR values of active UC patients and controls were 4.12 ± 1.41 and 1.68 ± 0.59, respectively (p = 0.000). The mean NLR values of inactive UC patients and controls were 1.55 ± 0.45 and 1.68 ± 0.59, respectively, thus NS. The mean NLR and other infl ammatory markers values of UC patients (active-inactive period) and controls are summarized in Table 2 . Table 3 shows that mean NLR values of active CD patients were signifi cantly higher than those of inactive CD patients (5.25 ± 1.85 vs 1.78 ± 0.32, p = 0.000). Mean NLR values of active UC patients were signifi cantly higher than those of inactive UC patients (4.12 ± 1.41 vs 1.55 ± 0.45, p = 0.000). Infl ammatory markers such as WBC, CRP and ESR, were found to be signifi cantly elevated in active CD and UC compared to those in inactive CD and UC.
Although Spearman correlation analysis in active CD indicated a signifi cant correlation of NLR with WBC (r = 0.242, p = 0.000) and neutrophil (r = 0.882, p = 0.000), no correlation was found with CRP (r = -0.61, p = 0.793) and ESR (r = 0.242, p = 0.291). Moreover, in inactive CD, negative correlation was found with lymphocytes (r = -0.615, p = 0.007). While Spearman correlation analysis in active and inactive UC indicated a signifi cant correlation of NLR with Neutrophil (r = 0.412, p = 0.007), (r = 0.515, p= 0.000), negative correlation was found with lymphocytes (r = -0.615, p = 0.000), (r = -0.451, p = 0.003) (Tab. 4). ROC curve analysis suggested that the optimum NLR cut-off point for active CD was 3.2 with a sensitivity, specifi city, PPV and NPV of 81 %, 59 %, 93 %, and 74 %, respectively (AUC -0.830). ROC curve analysis suggested that the optimum NLR cut-off point for active UC was 3.1 with a sensitivity, specifi city, PPV and NPV of 78 %, 69 %, 84 %, and 64 %, respectively (AUC -0.740) (Tab. 5, Figs 1 and 2 ).
Discussion
Our study's aim relates to the identifi cation of NLR as a new noninvasive marker of disease severity in subjects with IBD. Our results demonstrate that values of NLR, CRP, ESR and WBC are higher in patients with active CD and UC compared with controls. The values of NLR, CRP and ESR were also found to be decreased after remission of CD and UC. Besides, the values of NLR and the other infl ammatory markers were higher in patients with active CD and UC compared with those in remission period.
While the values of NLR were positively correlated with WBC and neutrophil in patients with active CD, it had a negative correlation with lymphocyte in patients with inactive CD. On the other hand, in patients with inactive or active UC it has been shown that while the values of NLR were positively correlated with neutrophil, they had a negative correlation with lymphocyte. Compared to inactive IBD and controls, high levels of N/L ratio in the sera of active IBD patients support the view that neutrophils may have a role in the infl ammatory cascade of IBD and disease pathophysiology.
Although clinical, histological, radiologic and endoscopic examinations are used to determine disease activity in IBD patients, a large number of invasive and non-invasive methods have also been investigated for IBD diagnosis and determination of disease activity (19, 21) . Although there is no ideal single serum marker for predicting disease severity, WBC, CRP and ESR are the most commonly used infl ammatory indices in routine clinical practice for determining IBD activity. These parameters can change according to the degree of the infl ammatory state, but they do not adequately refl ect disease activity because of their low sensitivity and specifi city for intestinal infl ammation (22) . Despite the better known role of infl ammatory cells in IBD pathogenesis, there are a few data in literature describing the role of NLR as a predictor of disease severity. In this context, this study was designed to evaluate the role of NLR in prediction of IBD activation in conjunction with other clinical and biochemical severity indices. NLR was described in cardiac and non-cardiac disorders (15, 23) . It was found that NLR was signifi cantly higher in patients with chronic renal failure than in the control group (24, 25) . Besides, it was found to be correlated with the activation of ulcerative colitis (26) . In many diseases with chronic infl ammation, NLR was found to be correlated with the levels of CRP, ESR and WBC, for example, in chronic renal failure and ulcerative colitis (23) (24) (25) (26) . NLR has been generally investigated as a prognostic index in infl ammatory and neoplastic diseases such as colorectal cancer, pancreatic cancer, hepatocellular and metastatic renal cell carcinoma, (27) (28) (29) . Furthermore, recent studies also suggest that NLR is useful for predicting survival following coronary interventions and non-ST-segment elevation myocardial infarction (13, 30, 31) . Moreover, based on the fi ndings of our study, we believe that a standardized cut-off value for NLR in estimating disease severity is crucial for initial evaluation. Because of the need for starting an optimal treatment as soon as possible, elevated NLR levels can give a signifi cant clue to the clinician for estimating disease severity.
The study has some limitations including crosssectional design and a relatively small sample size. Our study was not designed to elucidate the mechanistic pathways that lead to higher N/L ratio in patients with IBD.
In brief, this study demonstrates that in subjects with IBD, the N/L ratio is strongly associated with active disease and correlated with clinical and laboratory indices. The N/L ratio is an inexpensive and easily applicable test. Although the certainty of N/L ratio for detecting active IBD is suboptimal, it can be measured easily and its combination with other markers assist to identify patients with increased risk of active disease. If our study can be taken forward with further trials, we think that a standardized cut-off value for NLR would simplify the diagnosis of IBD activation.
